Remogliflozine Etabonate 50.00 mg

REMO 50MG is a medication available in tablet form. Each tablet contains 50.00mg of Remogliflozine Etabonate, which belongs to the class of medications known as sodium-glucose co-transporter-2 (SGLT2) inhibitors. REMO 50MG is primarily prescribed for the management of type 2 diabetes mellitus. It works by reducing the reabsorption of glucose in the kidneys, thereby increasing urinary glucose excretion and lowering blood sugar levels. It is usually used in combination with diet and exercise to improve glycemic control in adult patients with diabetes.

Take REMO 50MG exactly as prescribed by your doctor. Swallow the tablet whole with a glass of water. It is usually taken once daily with or without food.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.